Issue 22, 2019

Protein deglycosylation can drastically affect the cellular uptake


Targeted drug delivery mediated by nanocarriers is a major issue in modern-day medicine. Upon coming in contact with biological fluids (e.g. blood), nanocarriers are rapidly covered by biomolecules (proteins, lipids, etc.) which results in the formation of a surface layer, widely known as the biomolecular corona. The biomolecular corona subsequently confers a certain biological identity to the corona-covered nanocarriers which can be crucial during their subsequent interactions with cells or other biological entities. In contrast to the proteins of the corona, little is known about the impact of the non-protein constituents of the corona, such as sugars. Here, we investigate the role of protein glycosylation of the corona in cellular uptake. We show that deglycosylation of clusterin (CLU) and apolipoprotein AI (Apo AI) significantly changes (increases and decreases, respectively) the cellular uptake of nanocarriers covered with these proteins.

Graphical abstract: Protein deglycosylation can drastically affect the cellular uptake

Supplementary files

Article information

Article type
13 Oct 2018
27 Apr 2019
First published
03 May 2019
This article is Open Access
Creative Commons BY license

Nanoscale, 2019,11, 10727-10737

Protein deglycosylation can drastically affect the cellular uptake

A. Ghazaryan, K. Landfester and V. Mailänder, Nanoscale, 2019, 11, 10727 DOI: 10.1039/C8NR08305C

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity